本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

33.28
+0.52001.59%
成交量:10.41万
成交额:342.24万
市值:10.17亿
市盈率:-50.87
高:33.35
开:32.79
低:32.23
收:32.76
52周最高:44.28
52周最低:17.72
股本:3,054.95万
流通股本:2,821.96万
量比:0.38
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
净资产收益率:-4.20%
总资产收益率:-1.36%
市净率:2.16
市盈率(LYR):-39.93

数据加载中...

2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

重要事件披露

Form 8-K - Current report